Parkinson’s disease imposes €22.8 billion economic burden across Europe
The annual societal cost of Parkinson’s disease across Europe reached €22.8 billion in 2019, equivalent to €28.8 billion…
Women with Parkinson’s may be more vulnerable to Alzheimer’s pathology
Women with Parkinson’s disease may be more vulnerable to Alzheimer’s-related changes in the brain than men, according to…
Neuroscience research questions traditional markers for cerebellar movement disorders
A new finding by a Virginia Tech neuroscientist at the Fralin Biomedical Research Institute at VTC is challenging the way…
Injectable wireless device offers new approach to control nerve activity
Researchers from NYU Abu Dhabi, in collaboration with Cleveland Clinic Abu Dhabi, have developed a tiny, injectable medical…
New decision tool helps Parkinson’s patients consider deep brain stimulation
Deciding if and when to pursue deep brain stimulation (DBS) can be overwhelming for people with Parkinson’s disease.…
Spiritual care should be routine for patients with neurological diseases
People living with neurological diseases such as Parkinson’s disease, dementia and epilepsy face not only physical decline, but…
Teva Pivot to Growth: Stepping Up Innovation
Now in its acceleration phase, Teva continues to step up innovation by working on breakthrough treatments for diseases…
Smartphones match traditional methods in monitoring patients with muscular dystrophy
Stanford Medicine researchers found that a smartphone could monitor patients with two types of muscular dystrophy as well…